Lite Strategy LITS
NASDAQ LITS
$0.99 +0.05 (+4.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Cash & Current Investments (2010 - 2026)

Lite Strategy (LITS) posted quarterly Cash & Current Investments of $7.5 million for Q1 2026, down 63.2% year-over-year from $20.5 million in Q1 2025, and down 13.86% quarter-over-quarter from $8.8 million in Q4 2025.

Lite Strategy (LITS) Cash & Current Investments (2010 - 2026) Analysis & Trends

Lite Strategy's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $7.5 million for Q1 2026.

  • In Q1 2026, Cash & Current Investments fell 63.2% year-over-year to $7.5 million; the TTM figure through Mar 2026 stood at $7.5 million (down 63.2% YoY), while the FY2025 annual figure was $18.0 million, down 53.03% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $7.5 million, down from $8.8 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $327.0 million in Q1 2022, with the low at $7.5 million in Q1 2026.
  • The 5-year median for Cash & Current Investments is $56.6 million (2024), against an average of $83.6 million.
  • The sharpest annual moves came in 2022 and 2023: Cash & Current Investments soared 98.62% in 2022, then tumbled 74.95% in 2023.
  • Lite Strategy's Cash & Current Investments stood at $237.4 million in 2022, then sank by 74.95% to $59.5 million in 2023, then tumbled by 60.15% to $23.7 million in 2024, then sank by 63.05% to $8.8 million in 2025, then retreated by 13.86% to $7.5 million in 2026.
  • Business Quant data shows LITS's Cash & Current Investments at $7.5 million in Q1 2026, $8.8 million in Q4 2025, and $10.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 Lite Strategy 35.71 Mn 28.17 Mn - 7.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.54 Mn
Dec 31, 2025 8.76 Mn
Sep 30, 2025 10.11 Mn
Jun 30, 2025 18.01 Mn
Mar 31, 2025 20.50 Mn
Dec 31, 2024 23.70 Mn
Sep 30, 2024 26.95 Mn
Jun 30, 2024 38.35 Mn
Mar 31, 2024 56.57 Mn
Dec 31, 2023 59.47 Mn
Sep 30, 2023 82.17 Mn
Jun 30, 2023 100.69 Mn
Mar 31, 2023 112.01 Mn
Dec 31, 2022 237.43 Mn
Sep 30, 2022 138.37 Mn
Jun 30, 2022 153.25 Mn
Mar 31, 2022 326.97 Mn
Dec 31, 2021 185.75 Mn
Sep 30, 2021 275.39 Mn
Jun 30, 2021 153.43 Mn